TransMedics Overview

  • Founded
  • 1998
Founded
  • Status
  • Public
  • Employees
  • 110
Employees
  • Stock Symbol
  • TMDX
Stock Symbol
  • Share Price
  • $14.42
  • (As of Thursday Closing)

TransMedics General Information

Description

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes the technology to replicate near-physiologic conditions for donor organs outside of the human body.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Stock Exchange
NAS
Primary Office
  • 200 Minuteman Road
  • Suite 302
  • Andover, MA 01810
  • United States
+1 (978) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

TransMedics Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$14.42 $15.48 $13.67 - $49.50 $430M 27.8M 205K -$1.37

TransMedics Financials Summary

In Thousands,
USD
TTM 30-Sep-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 838,506 442,311 348,072
Revenue 28,221 25,639 23,604 13,017
EBITDA (32,181) (23,154) (27,932) (20,226)
Net Income (37,858) (28,748) (33,547) (23,756)
Total Assets 131,146 152,026 105,299 42,157
Total Debt 35,058 34,657 34,146 33,670
Public Fundamental Data provided by Morningstar, Inc. disclaimer

TransMedics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore TransMedics‘s full profile, request access.

Request a free trial

TransMedics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore TransMedics‘s full profile, request access.

Request a free trial

TransMedics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-sta
Surgical Devices
Andover, MA
110 As of 2020
00000
0000 0000-00-00
00000000 00000

0000000

o eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud
00000 0000000 000 00000000
Oxford, United Kingdom
00 As of 0000
0000
0000000000 0 0000

00000000

reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaeca
00000000 0000000
New York, NY
000 As of 0000
000.00
000000 - 000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

TransMedics Competitors (17)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
OrganOx Venture Capital-Backed Oxford, United Kingdom 00 0000 0000000000 0 0000
0000000000000 Corporation New York, NY 000 000.00 000000 - 000 000.00
00000000 000000000 Venture Capital-Backed Tel Aviv, Israel 00 000.00 0000000000 0 000.00
000000 0000000 000 Formerly PE-Backed Rochester, MN 00 000000000000
0000000 Venture Capital-Backed Naples, FL 0000 00000 0000000000 0 00000
You’re viewing 5 of 17 competitors. Get the full list »

TransMedics Patents

TransMedics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2997267-A1 Aortic cannula for ex vivo organ care system Pending 09-Sep-2015 0000000000
AU-2016318622-B2 Aortic cannula for ex vivo organ care system Active 09-Sep-2015 000000000 0
US-20170064943-A1 Aortic cannula for ex vivo organ care system Granted 09-Sep-2015 0000000000 0
EP-3824731-A1 Aortic cannula for ex vivo organ care system Pending 09-Sep-2015 000000000
AU-2016318622-A1 Aortic cannula for ex vivo organ care system Granted 09-Sep-2015 A01N1/0247
To view TransMedics’s complete patent history, request access »

TransMedics Executive Team (16)

Name Title Board Seat Contact Info
Waleed Hassanein MD Chief Executive Officer & Board Member
Stephen Gordon Chief Financial Officer, Finance & Secretary, Administration
Tamer Khayal MD Executive
John Carey Vice President
John Sullivan Vice President
You’re viewing 5 of 16 executive team members. Get the full list »

TransMedics Board Members (15)

Name Representing Role Since
Adam Grosser Self Board Member 000 0000
David Abrams Abrams Capital Management Board Member 000 0000
Earl Collier JD Self Board Member 000 0000
Edward Basile JD TransMedics Board Member 000 0000
Edwin Kania Jr. Flagship Pioneering Board Member 000 0000
You’re viewing 5 of 15 board members. Get the full list »

TransMedics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial